May 05, 2021
Graduate student Maria McSharry explores the Science Education Journal Club and founder Danielle Spitzer’s efforts to promote evidence-based teaching strategies on campus.
April 27, 2021
Rachel Bernstein, PhD, is a the editor of Science Careers. Bernstein is joining the QB3-Berkeley Professionals in Residence (PIR) program on May 6 and May 13. Graduate students and postdocs may register for Bernstein’s PIR visit here. Bernstein spoke with graduate student Kaydren Orcutt about her journey from science writing to writing about the scientific community, and how her experiences at UC Berkeley helped shape her career.
April 22, 2021
University of California, Berkeley, scientists have now invented a way to make these compostable plastics break down more easily, with just heat and water, within a few weeks, solving a problem that has flummoxed the plastics industry and environmentalists.
April 19, 2021
Applications are now open for QB3-Berkeley’s graduate student and postdoc science writing workshop, Science Writing for the Public: Share Your Research and Connect with Audiences. This three-part workshop will give participants training in writing science communications for a general audience.
April 13, 2021
A recent work published by the Schepartz laboratory at the UC Berkeley Department of Chemistry explores how a short helical protein can facilitate the delivery of proteins into cells, potentially offering scientists a streamlined method to efficiently deliver therapeutics to patients
April 12, 2021
Christopher J. Chang is one of this year’s 184 John Simon Guggenheim Memorial Foundation fellows. The prestigious awards recognize scholars with impressive achievements in fields ranging from the natural sciences to the creative arts.
April 12, 2021
Tailocins, which are extremely strong protein nanomachines made by bacteria, and their functions are an area of hot research due to their many possible applications. Scientists at the Berkeley Lab explored the genetic basis and physical mechanisms governing how tailocins attack specific strains, and looked at genetic similarities and differences between tailocin producers and their target strains.
April 06, 2021
Mike Holmes, PhD, is the Chief Scientific Officer at Ambys Medicines and is joining the QB3-Berkeley Professionals in Residence (PIR) program on April 16th and 23rd. He spoke with PhD student Diana Aguilar Gómez about his career from being a graduate student to industry and his pioneering work in genome editing techniques in gene therapy.